{"id":938306,"date":"2026-02-19T13:31:56","date_gmt":"2026-02-19T18:31:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/"},"modified":"2026-02-19T13:31:56","modified_gmt":"2026-02-19T18:31:56","slug":"ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/","title":{"rendered":"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p>\nGE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nSIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in remote settings.<\/p>\n<\/li>\n<li>\nSIGNA Bolt, a new 3T MRI scanner, is engineered to support precision diagnostics, clinical efficiency, and advanced research capability.<\/p>\n<\/li>\n<li>\nBoth new systems are powered by SIGNA One, an ecosystem of AI-driven workflow solutions designed to reduce inefficiencies and support MRI exams from plan to scan and beyond.<\/p>\n<\/li>\n<\/ul>\n<p>CHICAGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): <b>SIGNA\u2122 Sprint with Freelium\u2122<\/b><sup>1<\/sup>, a 1.5T sealed magnet MRI system; <b>SIGNA\u2122 Bolt<\/b><sup>2<\/sup>, an advanced 3T MRI scanner; and <b>SIGNA\u2122 One<\/b><sup>3<\/sup>, an AI-driven ecosystem of workflow solutions designed to help reduce inefficiencies and support MRI exams from plan to scan and beyond.<\/p>\n<p>\nThe new MRI systems and technology combat some of the most complex challenges facing the radiology landscape from a rising demand in procedures caused by a growing aging population, increase in disease incidences, workforce burnout and sustainability expectations. These regulatory milestones signal a significant step forward in GE HealthCare\u2019s multi-year strategy to deliver a new wave of innovation and further differentiate its MR portfolio.<\/p>\n<p>\n\u201cAchieving FDA clearance of our next-generation SIGNA MRI technology underscores our commitment to expanding access to high-quality imaging and elevating the standard of care for patients everywhere,\u201d said Kelly Londy, President and CEO, MR at GE HealthCare. \u201cAs MRI demand continues to rise across clinical areas, providers need solutions that deliver greater efficiency without compromising diagnostic precision. With this new SIGNA generation, we\u2019re redefining what\u2019s possible \u2013 aiming to bring smarter, faster, more sustainable and more consistent imaging to more patients, across more settings, with confidence.\u201d<\/p>\n<p><b>Delivering benefits of helium-free technology: SIGNA Sprint with Freelium<\/b><\/p>\n<p>\nGE HealthCare\u2019s new sealed magnet 1.5T MRI system \u2013 <b>SIGNA Sprint with Freelium<\/b> \u2013 offers helium-free technology without compromising clinical or operational efficiency. With less than 1% helium usage<sup>4<\/sup>, SIGNA Sprint with Freelium provides helium independence without driving higher power consumption requirements or sacrificing image quality. The system supports remarkable image quality through exceptional homogeneity, high signal-to-noise ratio (SNR) and image clarity, integrated with deep learning solutions, including AIR\u2122 Recon DL and Sonic DL with a wide coverage of anatomies and clinical application. The system provides consistent clarity and diagnostic confidence, and offers:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n&gt;5-hour ride-through time, which enables the Freelium magnet to withstand short and prolonged power outages avoiding operational disruption<\/p>\n<\/li>\n<li>\nIdentical high homogeneity specification as conventional magnet technology, ensuring the same excellent image quality<\/p>\n<\/li>\n<li>\nThe same power infrastructure as current conventional magnet, providing helium independence without increasing power consumption<\/p>\n<\/li>\n<\/ul>\n<p>\nDesigned for maximum siting flexibility, SIGNA Sprint with Freelium features a ventless magnet that enables installation virtually anywhere \u2014 from major hospitals to remote regions \u2014 expanding access to advanced MR capabilities. The system also introduces two levels of operational autonomy: Scanning Autonomy through the intuitive SIGNA One interface to simplify workflows across technologist experience levels, and autonomous magnet monitoring, protection and recovery with intelligent sensors that automate ramp-down and ramp-up processes without requiring a field engineer \u2014 supporting uptime and reducing service dependency.<\/p>\n<p><b>Elevating the Premium Tier: SIGNA Bolt 3T<\/b><\/p>\n<p><b>SIGNA Bolt<\/b> is GE HealthCare\u2019s next-gen 3T MRI scanner, engineered to deliver precision diagnostics through powerful performance and sustainable design. Built on a deep learning foundation, the system streamlines clinical workflows and supports end-to-end imaging pathways while maintaining low energy consumption and operational costs.<\/p>\n<p>\nAt its core is an advanced 80\/200 gradient system that delivers research-level performance with approximately 30% lower power consumption compared to previous-generation systems, enabling gradient capability. SIGNA Bolt also introduces a new AIR\u2122 Coil suite designed to enhance patient comfort and operational flexibility, including feet-first capabilities across exams to better support claustrophobic patients and help reduce costly rescans. SIGNA Bolt provides end-to-end advanced solutions supporting care pathways such as neurology and oncology.<\/p>\n<p>\nThe system\u2019s sustainable infrastructure profile further differentiates its value proposition:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nUp to 65% reduction in peak power demand<sup>5<\/sup><\/li>\n<li>\nUp to 34% reduction in minimum equipment room space<sup>5<\/sup><\/li>\n<\/ul>\n<p><b>Enhancing workflow with AI-driven solutions: SIGNA One<\/b><\/p>\n<p>\nSIGNA Sprint with Freelium and SIGNA Bolt are powered by <b>SIGNA One,<\/b> a new AI-powered workflow ecosystem that offers solutions to improve the imaging experience and streamline MRI operations. By addressing inefficiencies across the MRI workflow, SIGNA One aims to help improve throughput, reduce variability and enhance the experience for both technologists and patients.<\/p>\n<p>\nThe SIGNA One platform integrates multiple core AI-enabled workflow solutions to enhance both the patient and user experience and elevate clinical confidence:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAn intuitive user experience that may help reduce training time with virtually zero learning curve, which boosts productivity for new and less experienced users<\/p>\n<\/li>\n<li>\nThe SIGNA One Table, designed to enhance patient comfort and simplify patient transport<\/p>\n<\/li>\n<li>\nA fully automated SIGNA One Camera with In-Room Console live feed, AI-enabled anatomical landmark localization and patient positioning verification, with real-time visual guidance on a touchscreen display \u2014 aiming to improve speed and accuracy of patient setup<\/p>\n<\/li>\n<li>\nContactless respiratory and peripheral gating designed to capture physiological data effortlessly, regardless of patient orientation and without the need for external devices<\/p>\n<\/li>\n<li>\nHigh-resolution, In-Room Consoles empowering technologists with simple patient setup control, aiming to minimize interruptions and maximizing throughput<\/p>\n<\/li>\n<\/ul>\n<p>\n\u201cAs imaging volumes continue to climb, we\u2019re under constant pressure to deliver answers faster without compromising diagnostic quality. What sets this new SIGNA MR platform apart is the focus on real-world clinical workflow. From the AI-driven automation to the dramatically streamlined setup and scanning process, we\u2019re seeing meaningful reductions in exam time and far greater consistency across technologists. It\u2019s a true leap forward in efficiency \u2013 one that will directly benefit both the patients we serve and our staff,\u201d said Dr. Tiron C.M. Pechet, Assistant Medical Director and CMIO at Shields Health. \u201cAt Shields, advancing imaging technology is central to who we are \u2014 particularly innovations that elevate both the care experience and image quality \u2014 and we\u2019re excited about the future impact technologies like this can have on the communities we serve.\u201d<\/p>\n<p><b>Advancing MR Leadership<\/b><\/p>\n<p>\nSince its spinoff from GE\u00a0in 2023, GE HealthCare has made significant investments to modernize and elevate its premium MR portfolio and strengthen its leadership position. The FDA clearances of SIGNA Sprint with Freelium, SIGNA Bolt and SIGNA One, with anticipated CE mark before the end of 2026, reflect the company\u2019s strategic focus on innovation, sustainability and productivity and its ambition to shape the future of MR imaging.<\/p>\n<p>\nTogether, these advancements reinforce GE HealthCare\u2019s commitment to partnering with healthcare providers to deliver precision care, improve operational performance and expand access to advanced imaging technologies.<\/p>\n<p>\nFor more information on next-gen SIGNA MR technology, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fgehealthcare.com%2Fproducts%2Fmagnetic-resonance-imaging&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=gehealthcare.com%2Fproducts%2Fmagnetic-resonance-imaging&amp;index=1&amp;md5=b33a02c805943bfab8072124a280cee5\">gehealthcare.com\/products\/magnetic-resonance-imaging<\/a>.<\/p>\n<p><b>About GE HealthCare Technologies Inc.<\/b><\/p>\n<p>\nGE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world\u2019s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.<\/p>\n<p>\nGE HealthCare is proud to be among <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Ffortune.com%252Franking%252Fworlds-most-admired-companies%252F%26data%3D05%257C02%257CKatherine.Scrivano%2540gehealthcare.com%257C486fef5569484d98adf208de64049a2a%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C639058168118340519%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DQjPga1PiA6ZbwVVK8Dix0hXvQlMhR0H50WeDJFMvzEQ%253D%26reserved%3D0&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=2026&amp;index=2&amp;md5=94e2fb0daeffeef53d1f76b19da33ecd\">2026 <\/a><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Ffortune.com%252Franking%252Fworlds-most-admired-companies%252F%26data%3D05%257C02%257CKatherine.Scrivano%2540gehealthcare.com%257C486fef5569484d98adf208de64049a2a%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C639058168118372220%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DstRa5izJFm6882SAszBP8aWXbuhGUc7bgS7B4eGiC%252FE%253D%26reserved%3D0&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=Fortune&amp;index=3&amp;md5=564d243713faac36af8df39ee0d7db94\"><i>Fortune<\/i><\/a><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Ffortune.com%252Franking%252Fworlds-most-admired-companies%252F%26data%3D05%257C02%257CKatherine.Scrivano%2540gehealthcare.com%257C486fef5569484d98adf208de64049a2a%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C639058168118677448%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DnJi9Tsv64%252BpIrRH%252Bnti%252BtXkpGsBY9YKapM0PUzHirBg%253D%26reserved%3D0&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=World%26%238217%3Bs+Most+Admired+Companies%26%238482%3B.&amp;index=4&amp;md5=f8c8a523c1766073b8d00fc061e1b7b5\"> World\u2019s Most Admired Companies\u2122.<\/a><\/p>\n<p>\nFollow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fgehealthcare%26data%3D05%257C02%257CKatherine.Scrivano%2540gehealthcare.com%257C486fef5569484d98adf208de64049a2a%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C639058168118707986%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DtTG5koXtzkQyU9lXW2YqmJSL53zI6%252FtelREucj7Go9k%253D%26reserved%3D0&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=6538b9c9fe682fb9532e70984f0c0c36\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.facebook.com%252FGEHealthCare%252F%26data%3D05%257C02%257CKatherine.Scrivano%2540gehealthcare.com%257C486fef5569484d98adf208de64049a2a%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C639058168118728519%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DxNlQH2suCmei%252FcNgy02sKbA7MKveVEY53jZFsaVy9eQ%253D%26reserved%3D0&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=Facebook&amp;index=6&amp;md5=e685b01c2d2a9f31d94e2f308b91ef22\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.instagram.com%252Fgehealthcare%252F%26data%3D05%257C02%257CKatherine.Scrivano%2540gehealthcare.com%257C486fef5569484d98adf208de64049a2a%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C639058168118744975%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DojLJnm7EsyLKPjzce%252FrRfYvS6qAkWWh77KMB8Y9%252FiYU%253D%26reserved%3D0&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=Instagram&amp;index=7&amp;md5=7ba77dbdc6062e0cefa73cd979907bb8\">Instagram<\/a>, or visit our website for our <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Fabout%2Fnewsroom&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=latest+news&amp;index=8&amp;md5=6c884be0e0da73cfc5a63936675353ba\">latest news<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Finsights%3FshowPopup%3Dfalse&amp;esheet=54428394&amp;newsitemid=20260218071310&amp;lan=en-US&amp;anchor=perspectives&amp;index=9&amp;md5=ba3f934eecfc6c0d03dd0485060b87c0\">perspectives<\/a>.<\/p>\n<p><sup>1<\/sup> SIGNA\u2122<b \/>Sprint with Freelium\u2122<b \/>is a sealed configuration of SIGNA\u2122<b \/>Sprint Select. SIGNA Sprint Select is 510(k) cleared by the FDA. Not CE marked. Not available for sale in all regions.<\/p>\n<p><sup>2<\/sup> SIGNA Bolt is 510(k) cleared by the U.S. FDA. Not CE marked. Not available for sale in all regions.<\/p>\n<p><sup>3<\/sup> SIGNA One represents features and content that are 510(k) cleared with SIGNA Bolt and SIGNA Sprint with Freelium by the U.S. FDA. Not CE marked. Not available for sale in all regions.<\/p>\n<p><sup>4<\/sup> Compared to conventional magnets.<\/p>\n<p><sup>5<\/sup> Compared to previous generation systems.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260218071310\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260218071310\/en\/<\/a><\/span><\/p>\n<p><b>GE HealthCare Media Contact:<br \/>\n<\/b><br \/>Katie Scrivano<br \/>\n<br \/>M +1 262-215-5281<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Katherine.Scrivano@gehealthcare.com\">Katherine.Scrivano@gehealthcare.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Illinois<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Medical Devices Hospitals FDA Health Technology Software Radiology General Health Health Artificial Intelligence<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260218071310\/en\/1907724\/3\/GE_HealthCare_logo_NEW_March_2023.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in remote settings. SIGNA Bolt, a new 3T MRI scanner, is engineered to support precision diagnostics, clinical efficiency, and advanced research capability. Both new systems are powered by SIGNA One, an ecosystem of AI-driven workflow solutions designed to reduce inefficiencies and support MRI exams from plan to scan and beyond. CHICAGO&#8211;(BUSINESS WIRE)&#8211; GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-938306","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in remote settings. SIGNA Bolt, a new 3T MRI scanner, is engineered to support precision diagnostics, clinical efficiency, and advanced research capability. Both new systems are powered by SIGNA One, an ecosystem of AI-driven workflow solutions designed to reduce inefficiencies and support MRI exams from plan to scan and beyond. CHICAGO&#8211;(BUSINESS WIRE)&#8211; GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the &hellip; Continue reading &quot;GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-19T18:31:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency\",\"datePublished\":\"2026-02-19T18:31:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/\"},\"wordCount\":1428,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/\",\"name\":\"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-02-19T18:31:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/","og_locale":"en_US","og_type":"article","og_title":"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency - Market Newsdesk","og_description":"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in remote settings. SIGNA Bolt, a new 3T MRI scanner, is engineered to support precision diagnostics, clinical efficiency, and advanced research capability. Both new systems are powered by SIGNA One, an ecosystem of AI-driven workflow solutions designed to reduce inefficiencies and support MRI exams from plan to scan and beyond. CHICAGO&#8211;(BUSINESS WIRE)&#8211; GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the &hellip; Continue reading \"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-19T18:31:56+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency","datePublished":"2026-02-19T18:31:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/"},"wordCount":1428,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/","name":"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-02-19T18:31:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260218071310r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ge-healthcare-achieves-mri-portfolio-milestone-with-fda-clearances-for-next-generation-signa-mri-technology-designed-to-enhance-precision-imaging-and-clinical-efficiency\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=938306"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/938306\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=938306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=938306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=938306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}